BriaCell Therapeutics Corp (BCTX) Stock Price, Quote, News & History

BCTXNASDAQ
$3.60
0.0150.42%
Last update: Sep 1, 3:09 PM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-30.82M
Investing Cash Flow (TTM)
-16.19M
Financing Cash Flow (TTM)
41.43M
Free Cash Flow (TTM)
-30.95M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-5.58M

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$8.30M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.30
Earnings Yield % (TTM)
-23.40%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.77

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$6.88M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$3.62
Close
-
Volume / Avg.
80.01K / 304.69K
Day Range
$3.50 - $3.65
52 Wk Range
2.60 - 14.68
Market Cap
$31.36M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
49
Short Interest
4.59%
Days to Cover
3.34

About

Sector
Health Care
Industry
Biotechnology
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherap...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy BriaCell Therapeutics (BCTX) stock?

A

You can purchase shares of BriaCell Therapeutics (NASDAQ:BCTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are BriaCell Therapeutics (BCTX) competitors?

Q

What is the forecast, or price target, for BriaCell Therapeutics (BCTX) stock?

A

BriaCell Therapeutics has a consensus price target of $40.00.

Q

What is the current price for BriaCell Therapeutics (BCTX)?

A

The stock price for BriaCell Therapeutics (NASDAQ: BCTX) is $3.605 last updated September 1, 2026 at 3:09 PM EDT.

Q

Does BriaCell Therapeutics (BCTX) pay a dividend?

A

There are no upcoming dividends for BriaCell Therapeutics.

Q

When is BriaCell Therapeutics (NASDAQ:BCTX) reporting earnings?

A

BriaCell Therapeutics does not have any upcoming earnings scheduled.

Q

Is BriaCell Therapeutics (BCTX) going to split?

A

There is no upcoming split for BriaCell Therapeutics.

Q

What sector and industry does BriaCell Therapeutics (BCTX) operate in?

A

BriaCell Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.